Prime Only Members-Only Article

No More Dying From COVID

New treatments will drastically reduce the death toll from COVID.
WASHINGTON, DC - JANUARY 19: (L-R) Douglas Emhoff, U.S. Vice President-elect Kamala Harris, Dr. Jill Biden and U.S. President-elect Joe Biden look down the National Mall as lamps are lit to honor the nearly 400,000... WASHINGTON, DC - JANUARY 19: (L-R) Douglas Emhoff, U.S. Vice President-elect Kamala Harris, Dr. Jill Biden and U.S. President-elect Joe Biden look down the National Mall as lamps are lit to honor the nearly 400,000 American victims of the coronavirus pandemic at the Lincoln Memorial Reflecting Pool January 19, 2021 in Washington, DC. As the nation's capital has become a fortress city of roadblocks, barricades and 20,000 National Guard troops due to heightened security around Biden's inauguration, 200,000 small flags were installed on the National Mall to honor the nearly 400,000 Americans killed by COVID-19. (Photo by Chip Somodevilla/Getty Images) MORE LESS
|
November 18, 2021 11:03 a.m.

I’ve mentioned a few times recently both Merck and Pfizer have new COVID-targeted anti-viral medications which dramatically reduce the chances of severe disease and death if taken early in the course of illness. Merck’s pill (molnupiravir) reduced the risk of hospitalization by 50% if taken within 5 days of symptom onset; Pfizer’s pill (paxlovid) reduced the risk of hospitalization by 85% if taken with 5 days onset and 89% if taken within three days.

Both treatments showed 100% efficacy against death.

Real Independence
Made Possible By Members

FREE community-supported memberships are available to students and those experiencing financial hardship

Special Offer
Prime
$60/yr
$60/yr
30% off!
Access to Member-Exclusives and Fewer Ads
Get Prime

    Also Includes:

  • The Hive Member Forum
  • Members-Only Newsletter
  • RSS Feeds
  • Commenting
Prime
$5.99/mo
Access to Member-Exclusives and Fewer Ads
Get Prime

    Also Includes:

  • The Hive Member Forum
  • Members-Only Newsletter
  • RSS Feeds
  • Commenting
Prime Ad Free
$100/yr
Access to Member-Exclusives and NO Ads
Get Prime AF

    Also Includes:

  • The Hive Member Forum
  • Members-Only Newsletter
  • RSS Feeds
  • Commenting
Prime Ad Free
$9.99/mo
Access to Member-Exclusives and NO Ads
Get Prime AF

    Also Includes:

  • The Hive Member Forum
  • Members-Only Newsletter
  • RSS Feeds
  • Commenting
See MonthlyAnnual Pricing Plans

More Membership Options

Student (free with .edu email) CREATE STUDENT ACCOUNT Community-Supported (free all-access membership) APPLY NOW TPM Inside LEARN MORE
CONTACT FAQ
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Investigations Desk:
Reporters:
Newswriters:
Director of Audience:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: